Capital Planning Advisors, LLC Abbott Laboratories Transaction History

Capital Planning Advisors, LLC

$639 Million
Q3 2024

A detailed history of Capital Planning Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 46,045 shares of ABT stock, worth $5.19 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

46,045

Previous 45,492 1.22%

Holding current value

$5.19 Million

Previous $4.73 Million 11.04%

% of portfolio

0.82%

Previous 0.83%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $55,338 - $65,325	553 Added 1.22%	46,045 $5.25 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $54,998 - $61,392	-546 Reduced 1.19%	45,492 $4.73 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $48,736 - $53,827	-445 Reduced 0.96%	46,038 $5.23 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $270 - $331	-3 Reduced 0.01%	46,483 $5.12 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $47,573 - $57,080	-498 Reduced 1.06%	46,486 $4.5 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $89,694 - $99,938	-890 Reduced 1.86%	46,984 $5.12 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $230,333 - $271,115	-2,378 Reduced 4.73%	47,874 $4.85 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $60,838 - $71,372	-640 Reduced 1.26%	50,252 $5.52 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $428,646 - $496,292	4,430 Added 9.53%	50,892 $4.92 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $1,735 - $2,097	17 Added 0.04%	46,462 $5.05 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $124,737 - $152,109	-1,094 Reduced 2.3%	46,445 $5.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $73,014 - $89,402	632 Added 1.35%	47,539 $6.69 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $25,781 - $28,522	-221 Reduced 0.47%	46,907 $5.54 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $292,826 - $344,699	-2,768 Reduced 5.55%	47,128 $5.46 Million
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $555,519 - $654,485	-5,104 Reduced 9.28%	49,896 $5.98 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $192,885 - $210,189	-1,837 Reduced 3.23%	55,000 $6.02 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $30,241 - $36,725	330 Added 0.58%	56,837 $6.19 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $73,660 - $94,276	962 Added 1.73%	56,507 $5.17 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $6,030 - $8,818	-96 Reduced 0.17%	55,545 $4.38 Million
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $55,035 - $61,267	701 Added 1.28%	55,641 $4.83 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $413,455 - $448,314	-5,052 Reduced 8.42%	54,940 $4.6 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $174,401 - $203,405	-2,393 Reduced 3.84%	59,992 $5.05 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $197,269 - $238,498	-2,979 Reduced 4.56%	62,385 $4.99 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $233,328 - $264,326	-3,559 Reduced 5.16%	65,364 $4.73 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.19 Million - $1.43 Million	19,521 Added 39.51%	68,923 $5.06 Million
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $1.06 Million - $1.17 Million	-18,420 Reduced 27.16%	49,402 $3.01 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $135,160 - $152,815	-2,402 Reduced 3.42%	67,822 $4.06 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $125,825 - $134,709	2,344 Added 3.45%	70,224 $4.01 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $3.26 Million - $3.64 Million	67,880	67,880 $3.62 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.

Account

Capital Planning Advisors, LLC Abbott Laboratories Transaction History